FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377019824> ?p ?o ?g. }

• W4377019824 endingPage "D150" @default.
• W4377019824 startingPage "D149" @default.
• W4377019824 abstract "Abstract Introduction Cardiovascular diseases (CVD) and Cancer (C), the most important causes of mortality worldwide. share many risk factors and common pathophysiological processes such as chronic inflammation and unfavorable cardio–metabolic profile. Progress in oncological treatments improved the survival of oncological patients (Pt) but have increased the likelihood of short– and long–term CV cardiovascular complications. The multidisciplinary collaboration between cardiologist and onco–hematologists is the task of Cardioncology, an emerging new sub–specialization of clinical cardiology that often make available personalized treatment with a favorable outcome also in clinically complex patients. Here we present a case of severe acute heart failure in a woman with advanced breast C (BC). Clinical Case 2021 April: 55–year–old woman with G3 BC, (ER 0%PgR 0%,Ki6770%HER2+) (T4N3M1), (chest wall and liver) on well tolerated treatment with Docetaxel X 6 and continuous double antiHER2 block (Trastuzumab + Pertuzumab) X 4 and steroids as ancillary therapy. After about 6 months of therapy a lower airways infection occurred and acute congestive heart failure (HF) with severe left ventricular systolic dysfunction (LVEF 25%) ensued requiring hospitalization in the ICU, where newly detected type II diabetes was diagnosed. Appropriate HF therapy with insulin and anticoagulant was established and congestive clinical state resolved. On outpatient basis B–Blocker and anti–RAAS therapy was titrated switching to empagliflozin. About 7 months after discharge, we registered the full recovery up to a normalization of systolic function (LVEF 55%) and the disappearance of the intraventricular thrombus. For progression of C, pt underwent chemotherapy with Capecitabine at metronomic and in October 2022 after cardio–oncological collegial discussion, anti–HER2 therapy resumed. Paz started Trastuzumab–Emtansine, well tolerated with substantial stability of the clinical picture (NYHA I–II) and instrumental and echocardiographic evaluation (LVEF 65%). Conclusions This clinical case reaffirms that close collaboration between cardiologist and oncologist is fundamental for the successful management of complex patients and surveillance must also extend during (and after) treatment. It also demonstrates that an early diagnosis and an evidence–based cardiological therapy can allow the recovery of the cardio–toxic effect of anti–HER2 drugs and may allow to resume the therapy successfully." @default.
• W4377019824 created "2023-05-19" @default.
• W4377019824 creator A5001322293 @default.
• W4377019824 creator A5004535385 @default.
• W4377019824 creator A5015950777 @default.
• W4377019824 creator A5022938359 @default.
• W4377019824 creator A5035108656 @default.
• W4377019824 creator A5049629149 @default.
• W4377019824 creator A5058532371 @default.
• W4377019824 creator A5076822338 @default.
• W4377019824 creator A5082731074 @default.
• W4377019824 creator A5083501037 @default.
• W4377019824 date "2023-05-01" @default.
• W4377019824 modified "2023-09-23" @default.
• W4377019824 title "P280 TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE–CHALLENGE OF DOUBLE ANTI–HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES" @default.
• W4377019824 doi "https://doi.org/10.1093/eurheartjsupp/suad111.354" @default.
• W4377019824 hasPublicationYear "2023" @default.
• W4377019824 type Work @default.
• W4377019824 citedByCount "1" @default.
• W4377019824 countsByYear W43770198242023 @default.
• W4377019824 crossrefType "journal-article" @default.
• W4377019824 hasAuthorship W4377019824A5001322293 @default.
• W4377019824 hasAuthorship W4377019824A5004535385 @default.
• W4377019824 hasAuthorship W4377019824A5015950777 @default.
• W4377019824 hasAuthorship W4377019824A5022938359 @default.
• W4377019824 hasAuthorship W4377019824A5035108656 @default.
• W4377019824 hasAuthorship W4377019824A5049629149 @default.
• W4377019824 hasAuthorship W4377019824A5058532371 @default.
• W4377019824 hasAuthorship W4377019824A5076822338 @default.
• W4377019824 hasAuthorship W4377019824A5082731074 @default.
• W4377019824 hasAuthorship W4377019824A5083501037 @default.
• W4377019824 hasBestOaLocation W43770198241 @default.
• W4377019824 hasConcept C121608353 @default.
• W4377019824 hasConcept C126322002 @default.
• W4377019824 hasConcept C134018914 @default.
• W4377019824 hasConcept C164705383 @default.
• W4377019824 hasConcept C2775887513 @default.
• W4377019824 hasConcept C2777180221 @default.
• W4377019824 hasConcept C2778198053 @default.
• W4377019824 hasConcept C2779786085 @default.
• W4377019824 hasConcept C2780591200 @default.
• W4377019824 hasConcept C530470458 @default.
• W4377019824 hasConcept C555293320 @default.
• W4377019824 hasConcept C71924100 @default.
• W4377019824 hasConcept C78085059 @default.
• W4377019824 hasConceptScore W4377019824C121608353 @default.
• W4377019824 hasConceptScore W4377019824C126322002 @default.
• W4377019824 hasConceptScore W4377019824C134018914 @default.
• W4377019824 hasConceptScore W4377019824C164705383 @default.
• W4377019824 hasConceptScore W4377019824C2775887513 @default.
• W4377019824 hasConceptScore W4377019824C2777180221 @default.
• W4377019824 hasConceptScore W4377019824C2778198053 @default.
• W4377019824 hasConceptScore W4377019824C2779786085 @default.
• W4377019824 hasConceptScore W4377019824C2780591200 @default.
• W4377019824 hasConceptScore W4377019824C530470458 @default.
• W4377019824 hasConceptScore W4377019824C555293320 @default.
• W4377019824 hasConceptScore W4377019824C71924100 @default.
• W4377019824 hasConceptScore W4377019824C78085059 @default.
• W4377019824 hasIssue "Supplement_D" @default.
• W4377019824 hasLocation W43770198241 @default.
• W4377019824 hasOpenAccess W4377019824 @default.
• W4377019824 hasPrimaryLocation W43770198241 @default.
• W4377019824 hasRelatedWork W2016532277 @default.
• W4377019824 hasRelatedWork W2167036398 @default.
• W4377019824 hasRelatedWork W2349315479 @default.
• W4377019824 hasRelatedWork W2364214674 @default.
• W4377019824 hasRelatedWork W2374022257 @default.
• W4377019824 hasRelatedWork W3033076790 @default.
• W4377019824 hasRelatedWork W3155674270 @default.
• W4377019824 hasRelatedWork W4200586754 @default.
• W4377019824 hasRelatedWork W4234660475 @default.
• W4377019824 hasRelatedWork W4308959595 @default.
• W4377019824 hasVolume "25" @default.
• W4377019824 isParatext "false" @default.
• W4377019824 isRetracted "false" @default.
• W4377019824 workType "article" @default.